1. Home
  2. TMDX vs PHI Comparison

TMDX vs PHI Comparison

Compare TMDX & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PHI
  • Stock Information
  • Founded
  • TMDX 1998
  • PHI 1928
  • Country
  • TMDX United States
  • PHI Philippines
  • Employees
  • TMDX N/A
  • PHI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PHI Telecommunications Equipment
  • Sector
  • TMDX Health Care
  • PHI Telecommunications
  • Exchange
  • TMDX Nasdaq
  • PHI Nasdaq
  • Market Cap
  • TMDX 4.0B
  • PHI 4.1B
  • IPO Year
  • TMDX 2019
  • PHI 1953
  • Fundamental
  • Price
  • TMDX $130.67
  • PHI $19.02
  • Analyst Decision
  • TMDX Buy
  • PHI Hold
  • Analyst Count
  • TMDX 12
  • PHI 1
  • Target Price
  • TMDX $128.92
  • PHI N/A
  • AVG Volume (30 Days)
  • TMDX 868.2K
  • PHI 110.7K
  • Earning Date
  • TMDX 10-29-2025
  • PHI 11-11-2025
  • Dividend Yield
  • TMDX N/A
  • PHI 6.34%
  • EPS Growth
  • TMDX 2163.11
  • PHI 20.57
  • EPS
  • TMDX 2.02
  • PHI 2.62
  • Revenue
  • TMDX $531,292,000.00
  • PHI $3,879,170,293.00
  • Revenue This Year
  • TMDX $38.78
  • PHI $3.27
  • Revenue Next Year
  • TMDX $20.76
  • PHI $3.07
  • P/E Ratio
  • TMDX $64.68
  • PHI $7.16
  • Revenue Growth
  • TMDX 48.09
  • PHI 2.02
  • 52 Week Low
  • TMDX $55.00
  • PHI $18.61
  • 52 Week High
  • TMDX $145.50
  • PHI $25.36
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 69.28
  • PHI 42.49
  • Support Level
  • TMDX $108.34
  • PHI $18.80
  • Resistance Level
  • TMDX $118.51
  • PHI $19.50
  • Average True Range (ATR)
  • TMDX 6.15
  • PHI 0.31
  • MACD
  • TMDX 1.78
  • PHI 0.11
  • Stochastic Oscillator
  • TMDX 86.45
  • PHI 42.86

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: